• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单酯和多酯级分对采用混合模式高效液相色谱-蒸发光散射检测器/蒸发光散射检测器和荧光胶束分析法进行聚山梨酯定量分析的影响。

Impact of mono- and poly-ester fractions on polysorbate quantitation using mixed-mode HPLC-CAD/ELSD and the fluorescence micelle assay.

作者信息

Lippold Steffen, Koshari Stijn H S, Kopf Robert, Schuller Rudolf, Buckel Thomas, Zarraga Isidro E, Koehn Henning

机构信息

F. Hoffmann-La Roche, Grenzacherstrasse 124, 4070 Basel, Switzerland.

Department of Chemical and Biomolecular Engineering, University of Delaware, 150 Academy Street, Newark, DE 19716, USA; Late Stage Pharmaceutical Development, Genentech, 1 DNA Way, South San Francisco, CA 94080, USA.

出版信息

J Pharm Biomed Anal. 2017 Jan 5;132:24-34. doi: 10.1016/j.jpba.2016.09.033. Epub 2016 Sep 26.

DOI:10.1016/j.jpba.2016.09.033
PMID:27693757
Abstract

Determination of excipient content in drug formulation is an important aspect of pharmaceutical formulation development and for analytical testing of the formulation. In this study, the influence of polysorbate subspecies, in particular mono- and poly-esters, for determining polysorbate (PS) content were investigated by comparing three of the most widely used PS quantitation approaches, the Fluorescence Micelle Assay (FMA) and Mixed-Mode High Performance Liquid Chromatography coupled with Charged Aerosol Detection (MM-CAD) or Evaporative Light Scattering Detection (MM-ELSD). FMA and MM-CAD were employed to investigate the quantitation behavior of PS20 and PS80 subspecies and corresponding degradation products in placebo formulations using forced degradation conditions at 40°C for up to 12 weeks. While both methods allowed accurate and comparable quantification of neat PS at the beginning of stress studies, pronounced differences in content determination between the methods were observed at later time points, which were attributable to substantial differences in the contribution of individual mono- and poly-esters to the overall quantitation results. It was particularly surprising to find that the main component of PS20, polyoxyethylene sorbitan monolaurate, did not show a signal at the studied concentration using FMA. Moreover, the degradation of polysorbate poly-esters, was reflected much stronger in FMA than MM-CAD results. Additional experiments employing chemical oxidation and base hydrolysis to degrade PS20, quantified by FMA and MM-ELSD, also show preferential reduction in certain subspecies depending on the degradation pathway involved. For PS20 degraded by chemical oxidation, quantitation results were lower for FMA than MM-ELSD, while the opposite trend was observed with base hydrolysis.

摘要

确定药物制剂中的辅料含量是药物制剂开发以及制剂分析检测的一个重要方面。在本研究中,通过比较三种最广泛使用的聚山梨酯定量方法,即荧光胶束分析法(FMA)以及与带电气溶胶检测(MM-CAD)或蒸发光散射检测(MM-ELSD)联用的混合模式高效液相色谱法,研究了聚山梨酯亚种,特别是单酯和多酯,对聚山梨酯(PS)含量测定的影响。采用FMA和MM-CAD研究了在40°C强制降解条件下长达12周时,PS20和PS80亚种以及相应降解产物在安慰剂制剂中的定量行为。虽然在应激研究开始时,这两种方法都能对纯PS进行准确且可比的定量,但在后期时间点观察到两种方法在含量测定上存在明显差异,这归因于各个单酯和多酯对总体定量结果的贡献存在显著差异。特别令人惊讶的是,发现使用FMA时,PS20的主要成分聚氧乙烯山梨醇酐单月桂酸酯在所研究的浓度下未显示信号。此外,聚山梨酯多酯的降解在FMA中的反映比MM-CAD结果要强得多。采用化学氧化和碱水解降解PS20并通过FMA和MM-ELSD进行定量的额外实验也表明,根据所涉及的降解途径,某些亚种会优先减少。对于通过化学氧化降解的PS20,FMA的定量结果低于MM-ELSD,而在碱水解时则观察到相反的趋势。

相似文献

1
Impact of mono- and poly-ester fractions on polysorbate quantitation using mixed-mode HPLC-CAD/ELSD and the fluorescence micelle assay.单酯和多酯级分对采用混合模式高效液相色谱-蒸发光散射检测器/蒸发光散射检测器和荧光胶束分析法进行聚山梨酯定量分析的影响。
J Pharm Biomed Anal. 2017 Jan 5;132:24-34. doi: 10.1016/j.jpba.2016.09.033. Epub 2016 Sep 26.
2
Characterization of Polysorbate Ester Fractions and Implications in Protein Drug Product Stability.聚山梨酯酯级分的特性及其对蛋白药物产品稳定性的影响。
Mol Pharm. 2020 Jul 6;17(7):2345-2353. doi: 10.1021/acs.molpharmaceut.0c00093. Epub 2020 Jun 5.
3
Acidic and alkaline hydrolysis of polysorbates under aqueous conditions: Towards understanding polysorbate degradation in biopharmaceutical formulations.在水相条件下聚山梨酯的酸碱性水解:探索聚山梨酯在生物制药制剂中的降解。
Eur J Pharm Sci. 2020 Mar 1;144:105211. doi: 10.1016/j.ejps.2019.105211. Epub 2020 Jan 10.
4
Mixed-mode and reversed-phase liquid chromatography-tandem mass spectrometry methodologies to study composition and base hydrolysis of polysorbate 20 and 80.混合模式和反相液相色谱-串联质谱法研究聚山梨酯 20 和 80 的组成和碱基水解。
J Chromatogr A. 2011 Apr 15;1218(15):2138-45. doi: 10.1016/j.chroma.2010.09.057. Epub 2010 Sep 29.
5
Characterization and stability study of polysorbate 20 in therapeutic monoclonal antibody formulation by multidimensional ultrahigh-performance liquid chromatography-charged aerosol detection-mass spectrometry.多维超高效液相色谱-电喷雾检测-质谱法分析治疗性单克隆抗体制剂中聚山梨酯 20 的特性和稳定性。
Anal Chem. 2014 May 20;86(10):5150-7. doi: 10.1021/ac5009628. Epub 2014 May 2.
6
Improving Prediction of Free Fatty Acid Particle Formation in Biopharmaceutical Drug Products: Incorporating Ester Distribution during Polysorbate 20 Degradation.提高生物制药制剂中游离脂肪酸粒子形成预测的准确性:在聚山梨酯 20 降解过程中考虑酯分布。
Mol Pharm. 2020 Nov 2;17(11):4354-4363. doi: 10.1021/acs.molpharmaceut.0c00794. Epub 2020 Oct 8.
7
Assessing the polysorbate degradation fingerprints and kinetics of lipases - how the activity of polysorbate degrading hydrolases is influenced by the assay and assay conditions.评估聚山梨酯降解指纹和脂肪酶动力学——聚山梨酯降解水解酶的活性如何受测定和测定条件的影响。
Eur J Pharm Sci. 2021 Nov 1;166:105980. doi: 10.1016/j.ejps.2021.105980. Epub 2021 Aug 20.
8
Degradation Mechanisms of Polysorbate 20 Differentiated by O-labeling and Mass Spectrometry.通过O标记和质谱法区分的聚山梨醇酯20的降解机制
Pharm Res. 2017 Jan;34(1):84-100. doi: 10.1007/s11095-016-2041-y. Epub 2016 Oct 13.
9
Analysis of polysorbate 80 and its related compounds by RP-HPLC with ELSD and MS detection.采用带蒸发光散射检测器(ELSD)和质谱(MS)检测的反相高效液相色谱法(RP-HPLC)分析聚山梨酯80及其相关化合物。
J Chromatogr Sci. 2012 Aug;50(7):598-607. doi: 10.1093/chromsci/bms035. Epub 2012 Apr 26.
10
Hydrolysis of Polysorbate 20 and 80 by a Range of Carboxylester Hydrolases.多种羧酸酯水解酶对聚山梨醇酯20和80的水解作用
PDA J Pharm Sci Technol. 2016 Jul-Aug;70(4):332-45. doi: 10.5731/pdajpst.2015.005942. Epub 2016 Mar 28.

引用本文的文献

1
Anomalous Clouding Behavior of Polysorbate 80─Deciphering the Role of Nonesterified Components.聚山梨醇酯80的异常浑浊行为——解析未酯化成分的作用
Mol Pharm. 2025 Jun 2;22(6):2917-2926. doi: 10.1021/acs.molpharmaceut.4c01268. Epub 2025 May 14.
2
Micellar Solvent Accessibility of Esterified Polyoxyethylene Chains as Crucial Element of Polysorbate Oxidation: A Density Functional Theory, Molecular Dynamics Simulation and Liquid Chromatography/Mass Spectrometry Investigation.酯化聚氧乙烯链的胶束溶剂可及性作为聚山梨酯氧化的关键因素:密度泛函理论、分子动力学模拟及液相色谱/质谱研究
Mol Pharm. 2025 Mar 3;22(3):1348-1364. doi: 10.1021/acs.molpharmaceut.4c01015. Epub 2025 Feb 3.
3
Polysorbates degrading enzymes in biotherapeutics - a current status and future perspectives.
生物治疗药物中的聚山梨酯降解酶——现状与未来展望
Front Bioeng Biotechnol. 2025 Jan 10;12:1490276. doi: 10.3389/fbioe.2024.1490276. eCollection 2024.
4
Stability of Protein Pharmaceuticals: Recent Advances.蛋白质类药物的稳定性:最新进展
Pharm Res. 2024 Jul;41(7):1301-1367. doi: 10.1007/s11095-024-03726-x. Epub 2024 Jun 27.
5
Discrimination of polysorbate 20 by high-performance liquid chromatography-charged aerosol detection and characterization for components by expanding compound database and library.通过高效液相色谱-带电气溶胶检测法鉴别聚山梨醇酯20,并通过扩展化合物数据库和谱库对其成分进行表征。
J Pharm Anal. 2024 May;14(5):100929. doi: 10.1016/j.jpha.2023.12.019. Epub 2023 Dec 30.
6
Comparative Stability Study of Polysorbate 20 and Polysorbate 80 Related to Oxidative Degradation.聚山梨醇酯20和聚山梨醇酯80与氧化降解相关的稳定性比较研究
Pharmaceutics. 2023 Sep 16;15(9):2332. doi: 10.3390/pharmaceutics15092332.
7
Oxidation of polysorbates - An underestimated degradation pathway?聚山梨酯的氧化——一种被低估的降解途径?
Int J Pharm X. 2023 Jul 27;6:100202. doi: 10.1016/j.ijpx.2023.100202. eCollection 2023 Dec 15.
8
Ceramic hydroxyapatite chromatography plays a critical role in bispecific antibody purification process for impurity removal.陶瓷羟基磷灰石色谱法在双特异性抗体纯化过程中去除杂质方面起着关键作用。
Antib Ther. 2022 Nov 19;6(1):30-37. doi: 10.1093/abt/tbac030. eCollection 2023 Jan.
9
The measurement and control of high-risk host cell proteins for polysorbate degradation in biologics formulation.生物制品制剂中聚山梨酯降解的高风险宿主细胞蛋白的测量与控制。
Antib Ther. 2022 Jan 15;5(1):42-54. doi: 10.1093/abt/tbac002. eCollection 2022 Jan.
10
Photo-Oxidation of Therapeutic Protein Formulations: From Radical Formation to Analytical Techniques.治疗性蛋白质制剂的光氧化:从自由基形成到分析技术
Pharmaceutics. 2021 Dec 28;14(1):72. doi: 10.3390/pharmaceutics14010072.